Background: Scoring first seems to be a determinant in professional football playing; several factors could influence the development of the match and the outcome. This study aimed to identify which factors could influence scoring first and impact match outcomes in professional European female football.
Methods: There were 504 official matches held on 74 match days during the 2018-2019 professional female European football seasons (, , and ), analysed using a notational and inferential assessment.
Results: There was a direct positive relationship ( < 0.05) between scoring first and winning the match; 75.9% of the winning teams scored first. Moreover, those teams that usually scored first had a better final league classification ( < 0.05). These relationships were not influenced by home or away conditions.
Conclusions: Scoring first is a determinant in the outcomes of professional European female football matches. Physical and tactical training and programming should focus on those variables, leading female teams to score first.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619132 | PMC |
http://dx.doi.org/10.3390/ijerph182212009 | DOI Listing |
Maturitas
January 2025
Theramex, London, UK. Electronic address:
Introduction: Despite research supporting menopause hormonal therapy for menopausal women, its use continues to decline in most European countries and the United States. Experts highlighted the need for global assessment tools to assist clinicians in evaluating treatment for symptomatic menopausal women, which led to the development of the Menopause Treatment Tool, with separate versions for women and healthcare professionals. Both versions of the tool focus on menopausal symptoms, risk levels and suggested actions; the women's tool is administered prior to the consultation, while the clinician tool is administered by the clinician during the clinical consultation.
View Article and Find Full Text PDFFront Antibiot
September 2024
Integrative Health Research, Department of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Introduction: Antimicrobial resistance (AMR) represents a persistent and ascensive global threat influenced by antibiotic misuse and overuse. In the Romanian context, patterns of antibiotic consumption and resistance within the healthcare system are marked in the red scenario on the European map. General practitioners and pharmacists, among others, play a major role in stewardship towards AMR.
View Article and Find Full Text PDFTherapie
December 2024
Science Po, université Paris-Cité, 75006 Paris, France.
France has been engaged in a legal and organisational transition for many years. It has had to adapt its national framework to the legal requirements of personal data protection, European ambitions and international competition. From the Data Protection Act of 1978 to the Healthcare System Transformation Act of 2019, reforms have strengthened requirements in terms of personal data protection, while opening the way to innovative uses.
View Article and Find Full Text PDFCroat Med J
December 2024
Haxhi Kamberi, Faculty of Medicine, University of Gjakova "Fehmi Agani", Str. "Sabrije Vokshi-Bija", n.n., 50 000 Gjakova, Kosovo,
Aim: To assess the behavioral correlates of health literacy (HL) among university students of health sciences in Kosovo, irrespective of their sociodemographic characteristics.
Methods: This cross-sectional study, carried out in Kosovo in 2024, enrolled 470 students of health sciences from the universities of Prishtina and Gjakova (86% women; mean age: 20.7±2.
Maturitas
November 2024
Hormone Hamburg, Hamburg, Germany. Electronic address:
Objective: To report patient-reported quality-of-life (QOL) outcomes in the DAYLIGHT study.
Study Design: DAYLIGHT was a phase 3b, randomized, double-blind, 24-week, placebo-controlled study. Participants were women aged ≥40 to ≤65 years with moderate to severe vasomotor symptoms (VMS) considered unsuitable for hormone therapy (HT) (contraindications, caution, stoppers, or averse) randomized 1:1 to placebo or fezolinetant 45 mg once daily.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!